NEW YORK , Aug. 14, 2024 /PRNewswire/ -- The global cementless total knee arthroplasty market size is estimated to grow by USD 4.60 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of 30.08% during the forecast period. Rising number of people diagnosed with arthritis is driving market growth, with a trend towards increasing number of outpatient knee replacement surgeries.
However, high cost of cementless tka poses a challenge. Key market players include Aesculap Implants Systems LLC, Allegra Orthopaedics Ltd., B.
Braun SE, Beijing Chunlizhengda Medical Instruments Co. Ltd., C2F Implants, Conformis Inc.
, Corin Group Plc, DJO Global Inc., Euromed Implants GmbH, Exactech Inc., GROUP FH ORTHO, Johnson and Johnson Services Inc.
, Medacta International SA, MicroPort Scientific Corp., Smith and Nephew plc, Stryker Corp., Symbios Orthopedie SA, United Orthopedic Corp.
, Waldemar Link GmbH and Co. KG, and Zimmer Biomet Holdings Inc..
Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report Market Driver The preference for outpatient knee replacement surgeries is on the rise due to several factors. Advancements in surgical techniques, implants, comprehensive blood management, multimodal pain management, and postoperative care management have made it possible for arthroplasty surgeons to perform these procedures without the need for extensive formal rehabilitation. Patients benefit from.